April 30, 2019 01:41 PM EDTUpdated May 22, 11:27 AM

As Merck celebrates rising flow of Keytruda cash, execs plot facility shutdowns, layoffs in $1.2B reorganization

While Merck was publicly celebrating its number 1 position in the PD-1/L1 market with lots of fresh growth to report in Q1, they quietly posted …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

As Mer­ck cel­e­brates ris­ing flow of Keytru­da cash, ex­ecs plot fa­cil­i­ty shut­downs, lay­offs in $1.2B re­or­ga­ni­za­tion